(Circulation. 1997;96:3416-3422.)
© 1997 American Heart Association, Inc.
Articles |
Increased Myocardial Muscarinic Receptor Density in Idiopathic Dilated Cardiomyopathy
An In Vivo PET Study
From Service de Medecine Nucléaire, Hopital Bichat, Paris (D.L.G., N.D.); Service de Cardiologie, Hopital Beaujon, Paris (A.C.-S.); and Service Hospitalier Frederic Joliot, Département de Recherche Médicale, DSV-CEA, Orsay, France (J.D., A.S., P.M.).
Correspondence to Dominique Le Guludec, Service de Médecine Nucléaire, Hôpital Bichat, 46 rue Henri Huchard, 75018 Paris, France.
Background Congestive heart failure is associated with decreased stimulated myocardial adenylate cyclase activity, increased Gi-binding protein, attenuated parasympathetic tone, and increased modulation of ß-adrenergic inotropic left ventricular stimulation by parasympathetic agonists. Despite these abnormalities, changes in the density or affinity of ventricular muscarinic receptors have not been demonstrated in patients.
Methods and Results The density and affinity constants of myocardial muscarinic receptors were evaluated noninvasively by means of positron emission tomography with 11C-MQNB (methylquinuclidinyl benzilate), a specific hydrophilic antagonist, in 20 patients with congestive heart failure due to idiopathic dilated cardiomyopathy (mean left ventricular ejection fraction, 22±9%) and compared with values in 12 normal subjects. The mean receptor concentration was significantly higher in patients than in control subjects (B'max, 34.5±8.9 versus 25±7.7 pmol/mL, P<.005), with no changes in affinity constants. The change in heart rate after injection of 0.6 mg of cold MQNB was lower in patients than in control subjects (34±20% versus 55±36%, P<.05), and receptor density correlated negatively with maximal heart rate in the patients (r=.45, P<.05).
Conclusions Congestive heart failure is associated with an upregulation of myocardial muscarinic receptors. This may be an adaptive mechanism to ß-agonist stimulation and should increase the number of potential targets for pharmacological intervention.
Key Words: receptors • heart failure • nervous system, autonomic
This article has been cited by other articles:
 |
|
 |
|
  A. N. Mazzadi, J. Pineau, N. Costes, D. Le Bars, F. Bonnefoi, P. Croisille, R. Porcher, and P. Chevalier Muscarinic Receptor Upregulation in Patients With Myocardial Infarction: A New Paradigm Circ Cardiovasc Imaging, September 1, 2009; 2(5): 365 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhang, A. Hu, H. Yuan, L. Cui, G. Miao, X. Yang, L. Wang, J. Liu, X. Liu, S. Wang, et al. A Missense Mutation in the CHRM2 Gene Is Associated With Familial Dilated Cardiomyopathy Circ. Res., June 6, 2008; 102(11): 1426 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Knuuti and F M Bengel Positron emission tomography and molecular imaging Heart, March 1, 2008; 94(3): 360 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. McCloskey, S. Turcato, G.-Y. Wang, L. Turnbull, B.-Q. Zhu, T. Bambino, A. P. Nguyen, D. H. Lovett, R. A. Nissenson, J. S. Karliner, et al. Expression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathy Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H205 - H212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-k. Wei, A. M. Ruknudin, M. Shou, J. M. McCurley, S. U. Hanlon, E. Elgin, D. H. Schulze, and M. C.P. Haigney Muscarinic Modulation of the Sodium-Calcium Exchanger in Heart Failure Circulation, March 13, 2007; 115(10): 1225 - 1233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Richardson, J. D. Kilts, and M. M. Kwatra Increased Expression of Gi-Coupled Muscarinic Acetylcholine Receptor and Gi in Atrium of Elderly Diabetic Subjects Diabetes, September 1, 2004; 53(9): 2392 - 2396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Merlet, L. Hittinger, J. L. Dubois-Rande, and A. Castaigne Myocardial Adrenergic Dysinnervation in Dilated Cardiomyopathy: Cornerstone or Epiphenomenon? J. Nucl. Med., April 1, 2002; 43(4): 536 - 539. [Full Text] [PDF]
|
|
|
|
|
|
N. Delahaye, D. Le Guludec, S. Dinanian, J. Delforge, M. S. Slama, L. Sarda, F. Dolle, H. Mzabi, D. Samuel, D. Adams, et al. Myocardial Muscarinic Receptor Upregulation and Normal Response to Isoproterenol in Denervated Hearts by Familial Amyloid Polyneuropathy Circulation, December 11, 2001; 104(24): 2911 - 2916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Carrio Cardiac Neurotransmission Imaging J. Nucl. Med., July 1, 2001; 42(7): 1062 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O.-E. Brodde and M. C. Michel Adrenergic and Muscarinic Receptors in the Human Heart Pharmacol. Rev., December 1, 1999; 51(4): 651 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M Borst, P. Szalai, N. Herzog, W. Kubler, and R. H Strasser Transregulation of adenylyl-cyclase-coupled inhibitory receptors in heart failure enhances anti-adrenergic effects on adult rat cardiomyocytes Cardiovasc Res, October 1, 1999; 44(1): 113 - 120. [Abstract] [Full Text] [PDF]
|
|